Provided by Tiger Fintech (Singapore) Pte. Ltd.

Edwards Lifesciences

70.33
-1.4700-2.05%
Post-market: 70.330.00000.00%19:57 EST
Volume:5.21M
Turnover:366.61M
Market Cap:41.35B
PE:10.09
High:71.53
Open:70.83
Low:69.33
Close:71.80
Loading ...

Edwards Lifesciences Corp. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
07 Dec 2024

Edwards Lifesciences: Balancing Optimism and Caution with a Hold Rating Amidst TAVR Uncertainties

TIPRANKS
·
06 Dec 2024

TD Cowen Sticks to Its Hold Rating for Edwards Lifesciences (EW)

TIPRANKS
·
06 Dec 2024

Balanced Outlook with Strategic Potential: A Hold Rating for Edwards Lifesciences

TIPRANKS
·
06 Dec 2024

Edwards Lifesciences: Stable Growth Amidst Mixed Financial Outlook Justifies Hold Rating

TIPRANKS
·
06 Dec 2024

Edwards Lifesciences Price Target Raised to $78.00/Share From $70.00 by Truist Securities

Dow Jones
·
06 Dec 2024

Globus Medical (GMED) Up 2.1% Since Last Earnings Report: Can It Continue?

Zacks
·
06 Dec 2024

Edwards Lifesciences Is Maintained at Outperform by RBC Capital

Dow Jones
·
05 Dec 2024

Edwards Lifesciences price target raised to $75 from $70 at Stifel

TIPRANKS
·
05 Dec 2024

Edwards Lifesciences price target raised to $78 from $70 at Truist

TIPRANKS
·
05 Dec 2024

Kratos XQ-58A Demonstrates Collaborative EW and Kill Chain Closure under USMC Control in Large Force Exercise

GlobeNewswire
·
05 Dec 2024

Edwards Lifesciences Is Maintained at Hold by Canaccord Genuity

Dow Jones
·
05 Dec 2024

Edwards Lifesciences price target raised to $75 from $70 at TD Cowen

TIPRANKS
·
05 Dec 2024

Edwards Lifesciences price target raised to $68 from $63 at Canaccord

TIPRANKS
·
05 Dec 2024

Truist Securities Adjusts Price Target on Edwards Lifesciences to $78 From $70, Keeps Hold Rating

MT Newswires Live
·
05 Dec 2024

Edwards Lifesciences Corp : Canaccord Genuity Raises Target Price to $68 From $63

THOMSON REUTERS
·
05 Dec 2024